PRALUENT
PRALUENT
Approved
DIN Number
02453819
Drug Class
Human
Market Date
May 18, 2016
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02453819
AIG Number0158030001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
C10AX14 ALIROCUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification24:06.24
Health Canada Classification
ACTIVE INGREDIENTS (1)
ALIROCUMABActive
Strength: 75 MG / ML
Monograph: ALIROCUMAB